Tuberculosis News and Research

Latest Tuberculosis News and Research

What are the implications of orangutan translocation risks in the COVID-19 era?

Can orangutan translocation pose infectious disease transmission and species conservation threats?

13 Dec 2021

New insights about COVID-19 vaccination rates among people living with HIV

The AIDS Clinical Trials Group, the largest global HIV research network, which recently expanded its focus to include evaluating outpatient treatment for COVID-19, today announced that insights around COVID-19 vaccination rates among people living with HV have been published in the Journal of Infectious Diseases.

10 Dec 2021

Report helps understand how inequalities hinder the fight against HIV, tuberculosis and malaria

Inequities have been widely acknowledged as barriers to achieving global and national goals and targets in HIV, TB and malaria programs. However, the magnitude and extent of underlying health inequalities have remained poorly documented and understood.

9 Dec 2021

Partnership develops stool sample processing kit to help inform WHO's policy update on childhood TB diagnosis

42 Technology, FIND, the global alliance for diagnostics, and Rutgers University have worked together to develop an innovative stool sample processing kit that has played a central role in informing the World Health Organization’s recent policy update to improve the diagnosis of tuberculosis in children.

9 Dec 2021

Children and other patients in Africa missed vital medical appointments due to COVID-19

Patients seeking treatment for HIV, malaria, tuberculosis, maternal and child health services missed vital appointments because of the pressures COVID-19 put on Africa's health systems, new research has found.

2 Dec 2021

Mtb's exotoxin secretion and trafficking mechanism revealed

Six years ago, Michael Niederweis, Ph.D., described the first known toxin of the deadly pathogen Mycobacterium tuberculosis (Mtb), an exotoxin that had gone undetected for 132 years.

25 Nov 2021

WHO’s C-TAP and MPP finalize licensing agreement with CSIC for COVID-19 serological antibody technology

WHO's COVID-19 Technology Access Pool and the Medicines Patent Pool today finalized a licensing agreement with the Spanish National Research Council for a COVID-19 serological antibody technology.

23 Nov 2021

Impact of ultraviolet disinfection on nosocomial transmission of SARS-CoV-2 and other infectious diseases

A new review article determines the role of UV disinfection for nosocomial transmission of COVID-19 and other infectious diseases.

22 Nov 2021

New art exhibition raises awareness of antimicrobial resistance

The UK Mission partnered with the Swedish Mission in Geneva to unveil a new art exhibition entitled 'The Silent Pandemic: No Time To Wait' to mark the start of World Antimicrobial Awareness Week today. Antimicrobial resistance (AMR) is one of the greatest public health threats facing the world.

17 Nov 2021

Researchers identify new group of antibacterial molecules

Researchers at Karolinska Institutet, Umeå University, and the University of Bonn have identified a new group of molecules that have an antibacterial effect against many antibiotic-resistant bacteria.

17 Nov 2021

Mycobacterium tuberculosis may induce resistance to secondary SARS-CoV-2 infection

The current study reveals that mice infected with mycobacterium tuberculosis are resistant to SARS-CoV-2 infection.

14 Nov 2021

ACTG announces launch of clinical trial evaluating a three-month TB treatment

The AIDS Clinical Trials Group (ACTG), the largest global HIV research network, today announced the launch of A5362 (CLO-FAST), a clinical trial studying a three-month clofazimine- and high-dose rifapentine-containing treatment regimen for people with drug-susceptible tuberculosis (TB).

10 Nov 2021

Labs with no one to run them: Why public health workers are fleeing the field

There were days, nights and weekends in the early months of the pandemic when Denise Von Bargen was the only person running covid tests at the public health lab in Ventura County. She once had eight or nine employees to assist her, but, one by one, they had all retired or left for other jobs.

2 Nov 2021

Areas with higher 1968 influenza pandemic mortality have lower COVID-19 deaths

A new study demonstrates the influence of prior infectious outbreaks in a large population on succeeding pandemic outcomes.

31 Oct 2021

'Theta activity' in the brain found to be divergent for people with mental health conditions

A new review of current literature, conducted by the Institute of Psychiatry, Psychology & Neuroscience at King's College London, has found that irregular responses in the brain to challenging tasks and mistakes could be key to understanding common links between abnormal behaviors in a range of mental illness and cognitive disorders.

28 Oct 2021

Investigational inhaled COVID-19 treatment graduates to phase 3 in ACTIV-2 trial

The AIDS Clinical Trials Group, the largest global HIV research network, which recently expanded its focus to include evaluating outpatient treatment for COVID-19, today announced that the external data and safety monitoring board (DSMB) has recommended that SNG001, an inhaled formulation of interferon beta, advance to phase 3 in the ACTIV-2 Outpatient Monoclonal Antibodies and Other Therapies Trial (ACTG A5401).

21 Oct 2021

New shorter treatment regimen found to be safer, more effective at treating drug-resistant TB

A new all-oral six-month treatment regimen is safer and more effective at treating rifampicin-resistant tuberculosis (RR-TB) than the current accepted standard of care, according to results announced at the 52nd Union World Conference on Lung Health.

20 Oct 2021

Implementation of WHO's recommended public health policies has been slow globally, says study

Karolinska Institute Implementation of WHO's recommended public health policies on alcohol, unhealthy foods and tobacco has been slow globally, according to a study led by researchers at Karolinska Institute and the London School of Hygiene & Tropical Medicine, published in the journal The Lancet Global Health.

20 Oct 2021

Researchers identify the genetic changes responsible for drug resistance in tuberculosis

Using cutting-edge genomic sequencing techniques, researchers at the University of Oxford have identified almost all the genomic variation that gives people resistance to 13 of the most common tuberculosis (TB) drug treatments.

19 Oct 2021

Research reveals how daily circadian rhythms help to change heart function

A new study has shown how circadian rhythms in heart cells help to change heart function over the course of the day and may explain why shift workers are more vulnerable to heart problems.

18 Oct 2021

Tuberculosis News and Research

Latest Tuberculosis News and Research

What are the implications of orangutan translocation risks in the COVID-19 era?

New insights about COVID-19 vaccination rates among people living with HIV

Report helps understand how inequalities hinder the fight against HIV, tuberculosis and malaria

Partnership develops stool sample processing kit to help inform WHO's policy update on childhood TB diagnosis

Children and other patients in Africa missed vital medical appointments due to COVID-19

Mtb's exotoxin secretion and trafficking mechanism revealed

WHO’s C-TAP and MPP finalize licensing agreement with CSIC for COVID-19 serological antibody technology

Impact of ultraviolet disinfection on nosocomial transmission of SARS-CoV-2 and other infectious diseases

New art exhibition raises awareness of antimicrobial resistance

Researchers identify new group of antibacterial molecules

Mycobacterium tuberculosis may induce resistance to secondary SARS-CoV-2 infection

ACTG announces launch of clinical trial evaluating a three-month TB treatment

Labs with no one to run them: Why public health workers are fleeing the field

Areas with higher 1968 influenza pandemic mortality have lower COVID-19 deaths

'Theta activity' in the brain found to be divergent for people with mental health conditions

Investigational inhaled COVID-19 treatment graduates to phase 3 in ACTIV-2 trial

New shorter treatment regimen found to be safer, more effective at treating drug-resistant TB

Implementation of WHO's recommended public health policies has been slow globally, says study

Researchers identify the genetic changes responsible for drug resistance in tuberculosis

Research reveals how daily circadian rhythms help to change heart function

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Tuberculosis News and Research

Latest Tuberculosis News and Research

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Newsletters you may be interested in